| Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. | None |
| Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). | None |
| Characterization of a c-met proto-oncogene activated in human xeroderma pigmentosum cells after treatment with N-methyl-N -nitro-N-nitrosoguanidine (MNNG). | None |
| The role of scatter factor and the c-met proto-oncogene in angiogenic responses. | None |
| Identification of tyrosine 489 in the carboxy terminus of the Tpr-Met oncoprotein as a major site of autophosphorylation. | None |
| Cloning and sequencing of a tpr-met oncogene cDNA isolated from MNNG-transformed human XP fibroblasts. | None |
| Pathways downstream of Shc and Grb2 are required for cell transformation by the tpr-Met oncoprotein. | None |
| Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors. | None |
| Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation. | None |
| Hepatoblastoma in an adult associated with c-met proto-oncogene imbalance. | None |
| Activation of the JNK pathway is essential for transformation by the Met oncogene. | None |
| Efficient cellular transformation by the Met oncoprotein requires a functional Grb2 binding site and correlates with phosphorylation of the Grb2-associated proteins, Cbl and Gab1. | None |
| Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors. | None |
| Gene structure of the human MET proto-oncogene. | None |
| A point mutation in the MET oncogene abrogates metastasis without affecting transformation. | None |
| Structural and functional characterization of the mouse c-met proto-oncogene (hepatocyte growth factor receptor) promoter. | None |
| Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth. | None |
| Signaling requirements for oncogenic forms of the Met tyrosine kinase receptor. | None |
| Regulation of the c-met proto-oncogene promoter by p53. | None |